Share-Based Compensation - Summary of Stock-based Compensation Expense (Detail) - USD ($) $ in Thousands |
3 Months Ended | |
|---|---|---|
Mar. 31, 2026 |
Mar. 31, 2025 |
|
| Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] | ||
| Share based compensation expense | $ 2,959 | $ 2,333 |
| Research and Development | ||
| Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] | ||
| Share based compensation expense | 424 | 684 |
| Clinical Operations, Net | ||
| Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] | ||
| Share based compensation expense | 126 | 93 |
| Sales and Marketing | ||
| Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] | ||
| Share based compensation expense | 657 | 451 |
| General and Administrative | ||
| Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] | ||
| Share based compensation expense | $ 1,752 | $ 1,105 |